457 KEYNOTE-495/KeyImPaCT: interim analysis of a randomized, biomarker-directed, phase 2 trial of pembrolizumab-based combination therapy for non–small cell lung cancer (NSCLC)

• Enriqueta Felip,
• Jianda Yuan,
• Lawrence Fong,
• Charu Aggarwal,
• Razvan Cristescu,
• Myung-Ju Ahn,
• Alexandra Snyder,
• Matthew Hellmann,
• Roy Herbst,
• Martin Gutierrez,
• Edward Garon,
• Jong-Seok Lee,
• Julie Kobie,
• Matthew Gubens,
• Daniel Shao Weng Tan,
• Joanne WY Chiu,
• James Chih-Hsin Yang,
• Giovanna Finocchiaro,
• Alexander Luft,
• Gregory Landers,
• Andrea Basso,
• Hua Ma,
• John Palcza

Affiliations

Enriqueta Felip

3Vall d’ Hebron Institute of Oncology, Barcelona, Spain

Jianda Yuan

Aff3 grid.51462.340000000121719952Immune Monitoring FacilitySloan Kettering Institute New York NY USA

Lawrence Fong

University of California San Francisco, San Francisco, California, USA

Charu Aggarwal

Aff452 grid.25879.310000000419368972University of Pennsylvania Philadelphia PA USA

Razvan Cristescu

Hospital Merck and Co., Inc

Myung-Ju Ahn

Aff1 0000 0001 2181 989Xgrid.264381.aDivision of Hematology-Oncology, Department of Medicine, Samsung Medical CenterSungkyunkwan University School of Medicine 81 Irwon-ro, Gangnam-Gu 60351 Seoul Republic of Korea

Alexandra Snyder

Aff41 0000 0001 2260 0793grid.417993.1Merck & Co. Kenilworth NJ USA

Matthew Hellmann

Aff1 grid.51462.340000000121719952Memorial Sloan Kettering Cancer Center New York NY USA

Roy Herbst

1Yale School of Medicine, New Haven, CT, USA

Martin Gutierrez

Hackensack University Medical Center, Hackensack, New Jersey, USA

Edward Garon

David Geffen School of Medicine, UCLA, University of California Los Angeles, Los Angeles, California, USA

Jong-Seok Lee

4National University Bundang Hospital, Seongnam-si, Korea, Republic of

Julie Kobie

18Merck and Co., Inc., Kenilworth, NJ, USA

Matthew Gubens

4University of California, San Francisco, San Francisco, CA, USA

Daniel Shao Weng Tan

6SingHealth Duke NUS Academic Medical, Singapore, Singapore

Joanne WY Chiu

8University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong

James Chih-Hsin Yang

10National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei City, Taiwan, Province of China

Giovanna Finocchiaro

12IRCCS Humanitas Research Hospital, Milan, Italy

Alexander Luft

14Leningrad Regional Clinical Hospital, St. Petersburg, Russian Federation

Gregory Landers

15The Oncology Centre, KwaZulu-Natal, South Africa

Andrea Basso

16Merck and Co., Inc., Kenilworth, NJ, USA

Hua Ma

16Merck and Co., Inc., Kenilworth, NJ, USA

John Palcza

16Merck and Co., Inc., Kenilworth, NJ, USA